Marchex (MCHX) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
14 May, 2026Executive summary
Q1 2026 revenue was $10.6 million, down from $11.4 million in Q1 2025, primarily due to legacy platform migration and customer run rate impacts.
Net loss for Q1 2026 was $1.7 million, an improvement from $2.0 million in Q1 2025, with Adjusted EBITDA loss narrowing to $0.1 million; excluding $0.7 million in reorganization/acquisition costs, Adjusted EBITDA would have been a $0.6 million gain.
Operating expenses decreased 10% year-over-year, driven by organizational realignment and lower personnel and share-based compensation costs.
The company is leveraging AI-powered solutions and deeper customer penetration, with new bundled AI products seeing strong initial adoption among top customers.
The company operates in a single segment focused on conversational analytics and related solutions.
Financial highlights
Q1 2026 revenue was $10.6 million, down from $10.8 million in Q4 2025 and $11.4 million in Q1 2025.
Gross margin for Q1 2026 was 60%, compared to 63% in Q1 2025.
Cash and cash equivalents at March 31, 2026, were $9.0 million, down from $9.9 million, mainly due to annual payroll and severance payments.
Operating cash flow for Q1 2026 was $(0.5) million, improved from $(2.6) million in Q1 2025.
Net loss for Q1 2026 was $1.7 million, compared to $2.0 million in Q1 2025.
Outlook and guidance
Q2 2026 revenue is expected to increase sequentially, with Adjusted EBITDA guidance raised to $1.6–$1.8 million from prior guidance of over $1 million.
Q3 2026 revenue and Adjusted EBITDA anticipated to further increase, potentially reaching $2 million standalone or $2.5 million if the Archenia acquisition closes.
Full-year 2026 revenue growth projected at a 10% run rate over 2025, with Adjusted EBITDA margins expected to reach 10% or more.
Management expects resources to be sufficient to fund operations for at least twelve months, but macroeconomic factors could impact plans.
Additional equity or debt financing may be needed to support acquisition strategy and long-term obligations.
Latest events from Marchex
- Board-approved Archenia acquisition aims to accelerate growth and margin expansion in 2026.MCHX
Proxy filing13 May 2026 - Acquisition of Archenia, Inc. for $10M in notes and up to 4M shares awaits stockholder approval.MCHX
Proxy filing12 May 2026 - 2025 revenue fell, but AI solutions and Archenia deal position for strong 2026 growth.MCHX
Q4 202530 Apr 2026 - Net loss narrowed and adjusted EBITDA improved as revenue is set to grow in Q3.MCHX
Q2 20242 Feb 2026 - Q3 2024 delivered $12.6M revenue, narrowed losses, and set the stage for AI-driven growth in 2025.MCHX
Q3 202417 Jan 2026 - 2025 is set for sequential growth and margin improvement, driven by new AI products and partnerships.MCHX
Q4 202424 Dec 2025 - Annual meeting to elect directors, ratify auditor, and highlight governance and compensation practices.MCHX
Proxy Filing1 Dec 2025 - Director elections, auditor ratification, and performance-based compensation highlight strong governance.MCHX
Proxy Filing1 Dec 2025 - Annual proxy details director elections, voting proposals, and governance disclosures.MCHX
Proxy Filing1 Dec 2025